HR-5926 : Still Just a Bill

Naloxone Guidelines Act of 2018

This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).

The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:

  • co-prescription with an opioid;
  • safe dosages;
  • prescription for non-patients; and
  • standing orders (i.e., orders that allow dispensing without a prescription).

Action Timeline

Action DateTypeTextSource
2018-05-23IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2018-05-23IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

William R. Keating [D] (MA-9)
See Cosponsors

Policy Area :

Health
Related Subjects
  • Drug, alcohol, tobacco use
  • Drug therapy
  • Health promotion and preventive care
  • Health technology, devices, supplies
  • Prescription drugs
Related Geographic Entities
Related Organizations

Related Bills

See Related Bills